The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity.
Marquez-Monino, M.A., Santiveri, C.M., de Leon, P., Camero, S., Campos-Olivas, R., Jimenez, M.A., Saiz, M., Gonzalez, B., Perez-Canadillas, J.M.(2024) Structure